@apfed.bsky.social

A heartfelt thank you to the incredible speakers who made EOS Connection 2026 so meaningful. Your expertise, passion, and commitment to the eosinophilic disease community made this year's conference truly unforgettable. #Thank25 #APFED25

Bild

Caring for a child with #EoE? Check out our free webinar on July 29 at 12 PM ET. Clinicians + a patient advocate sharing real guidance for families at every stage. Supported by @PeerView and Boston University Chobanian & Avedisian School of Medicine CCE. Don't miss it! Register at apfed.org/webinars

Bild

‼️ Encouraging news for the EG community! A new study from the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) found dupilumab improved outcomes for eosinophilic gastritis, an important step toward better treatments. Read more: https://ow.ly/UgfZ50ZiVVF

Dupilumab Improves Outcomes for Individuals with Eosinophilic Gastritis

A new study from the Consortium of Eosinophilic Gastrointestinal Disease Researchers shows that dupilumab improves outcomes in eosinophilic gastritis.

ow.ly

Every diagnosis given today stands on the shoulders of scientists who spent years asking the right questions. We honor the researchers and pioneers whose work first defined eosinophil-associated diseases and whose dedication made it possible for patients to finally have answers.

Bild

We’re encouraged to see the FDA approval of Fasenra® (benralizumab) for adults and children ages 12+ living with hypereosinophilic syndrome (HES) when the condition is not caused by another underlying non-blood-related condition. Read the announcement from AstraZeneca: https://bit.ly/493wLpr #HES

Our Medical Advisory Board brings world-class expertise to everything from patient education to research priorities, ensuring that the resources we provide are accurate, current, and truly life-changing. We are deeply honored by their commitment to this community. #APFED25 #Thank25 #25for25

Bild

For people with EoE, eating is complicated. Elimination diets, symptom fear & swallowing discomfort can overlap with Avoidant/Restrictive Food Intake Disorder (ARFID). Know what to look for. apfed.org/blog

Bild

The bipartisan Medical Foods & Formulas Access Act (S.3304 / H.R.5684) would require Medicaid, CHIP, Medicare, and FEHBP to cover medically necessary formulas for digestive and metabolic disorders, including EGIDs. Urge Congress to co-sponsor. Take action: nutritionequity.org

Bild

Registration is now open! Tuesday, February 10, 2026 at 12:00 PM ET A 60-minute webinar with Rula Haji-Ali, MD, a rheumatologist at the Cleveland Clinic, who will discuss the neurological impacts of eosinophilic granulomatosis with polyangiitis (EGPA). To register, visit: apfed.org/events/eos-s...

Bild

📣New podcast episode on navigating your medical bills: apfed.org/podcast! Our latest episode "Tips for Understanding Your Medical Bills" features Beth Morgan, a medical billing advocate and consultant. 🎙️Catch prior episodes + subscribe to our podcast through Amazon Music, Apple, Spotify, and more!

Bild

Check out APFED's new podcast episode, "HOPE on the Horizon" with featured guest Fei Li Kuang, MD, PhD. Kuang, an allergist and immunologist at Northwestern Medicine, talks about receiving two APFED HOPE on the Horizon Grants and the research these grants support. apfed.org/podcast. #APFED #EosAware

Bild

APFED is excited to release our latest podcast episode, "HOPE on the Horizon" w/ featured guest Fei Li Kuang, MD, PhD: apfed.org/podcast. Kuang, an allergist and immunologist at Northwestern Medicine, talks about receiving two APFED HOPE on the Horizon Grants and the research these grants support.

Bild